VENTRIS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 08 Oct 2025)
What this means for you
Registered since 02 Jun 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 02 Jun 2030: the §8 & §9 renewal).
Record
- Serial number
- 88616059
- Registration number
- 6071147
- Mark type
- Word mark
- Filed
- 13 Sept 2019
- Published for opposition
- 28 Jan 2020
- Registered
- 02 Jun 2020
- Next maintenance filing
- §8 & §9 renewal, due by 02 Jun 2030 (grace period to 02 Dec 2030)
- Attorney of record
- Peter J. Willsey
Goods and services
- Class 005 — Pharmaceuticals: Biological allograft tissue used for medical purposes; Synthetic materials, namely, bovine collagen used for tissue healing for medical purposes
- Class 010 — Medical apparatus: Synthetic biomaterials used for bone grafts in orthopedic procedures; Anti-migration system comprised of synthetic bone graft materials
Owner
- Secada Medical LLC, Newport Beach, CA, US
- Secada Medical LLC, Newport Beach, CA, US
- Secada Medical LLC, Newport Beach, CA, US
Prosecution history
- 08 Oct 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 08 Oct 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 08 Oct 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Aug 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 Aug 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 12 Aug 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 12 Aug 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 04 Jun 2025 — TEAS SECTION 8 & 15 RECEIVED
- 02 Jun 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 19 Feb 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Feb 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 Feb 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 02 Jun 2020 — REGISTERED-PRINCIPAL REGISTER
- 30 Apr 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED